openPR Logo
Press release

Uveitis Treatment Market: Trends, Competitors, and Growth Opportunities 2023-2028

10-09-2023 12:55 PM CET | Health & Medicine

Press release from: IMARC Group

Uveitis Treatment Market Report 2023

Uveitis Treatment Market Report 2023

The global uveitis treatment market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 4.3% during 2023-2028.

Uveitis refers to a condition that causes inflammation of the middle layer of tissue in the eyewall uvea. It causes swelling that can damage the eye tissues, leading to poor vision or blindness. Uveitis is mainly caused by autoimmune diseases in which the body attacks itself, causing inflammation, infection and tumor in the eyes or other parts of the body. The treatment for uveitis involves a therapeutic process that can heal the inflammation of the uvea and surrounding tissues. It is treated with the help of drugs such as cycloplegic agents, anti-inflammatory, antimicrobials, as well as immunotherapy and targeted therapies. Uveitis treatment also provides the patient with relief from the pain, prevents further damage of the tissues, and restores vision loss.

Uveitis Treatment Market Trends:

The market is driven by the increasing prevalence of uveitis and other infectious eye disorders in individuals. Besides this, the growing awareness regarding the need for proper treatment among patients is also encouraging the adoption of advanced therapeutics. In addition to this, the rising complication associated with uveitis has resulted in increased investment in healthcare, thereby fueling the market growth. Furthermore, individualswith diabetes, eye injuries, cataracts, glaucoma, band keratopathy, and inflammatory disorders are more susceptible to uveitis. As a result, governments of different nations are taking initiatives to accelerate the approval of drugs in the pipeline and new routes of drug administration to improve the efficacy of the drugs. In addition to this, there has been a rise in the number of clinical trials for eye inflammation treatments for refractory posterior and intermediate uveitis across the globe. Nowadays, several leading manufacturers have increased their production capacity of the medication. Moreover, extensive research and development (R&D) activities in the field of ophthalmology have led to the introduction ofadvanced uveitis treatment, creating lucrative opportunities in the market. Looking forward, the market is expected to grow at a CAGR of 4.3% during the forecast period (2023-2028).

Request Sample Report: https://www.imarcgroup.com/uveitis-treatment-market/requestsample

Uveitis Treatment Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AbbVie Inc.
Alimera Sciences Inc.
Bausch & Lomb Incorporated (Bausch Health)
Enzo Biochem Inc.
Eyegate Pharmaceuticals Inc.
Eyepoint Pharmaceuticals Inc.
Novartis AG
Regeneron Pharmaceuticals Inc.
Santen Pharmaceutical Co. Ltd.

The report has segmented the market on the basis on region, Treatment Type, Disease Type, Cause and Distribution Channel.

Breakup by Treatment Type:

Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics

Breakup by Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

Breakup by Cause:

Infectious
Non-infectious

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Breakup by Region:

North America: United States, Canada
Asia Pacific: China, Japan, India, South Korea, Australia, Indonesia, Others
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Others
Latin America: Brazil, Mexico, Other
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2759&flag=C

Key highlights of the report:

Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Treatment Market: Trends, Competitors, and Growth Opportunities 2023-2028 here

News-ID: 3240799 • Views:

More Releases from IMARC Group

Taiwan Construction Market Size, Share, In-Depth Insights, Trends and Forecast 2026-2034
Taiwan Construction Market Size, Share, In-Depth Insights, Trends and Forecast 2 …
IMARC Group has recently released a new research study titled "Taiwan Construction Market Report by Sector (Residential, Commercial, Industrial, Infrastructure (Transportation), Energy and Utilities Construction), and Region 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Market Overview The Taiwan construction market size reached USD 37.4 Billion in 2025 and is projected to grow to USD 50.4
Mexico Whiskey Market Size to Hit USD 1,468.1 Million by 2034: Trends & Forecast
Mexico Whiskey Market Size to Hit USD 1,468.1 Million by 2034: Trends & Forecast
IMARC Group has recently released a new research study titled "Mexico Whiskey Market Size, Share, Trends and Forecast by Product Type, Quality, Distribution Channel, and Region, 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Market Overview The Mexico whiskey market size reached USD 905.2 Million in 2025. It is projected to grow to USD 1,468.1 Million
Mexico LED Lights Market 2026 : Industry Size to Reach USD 2,904.4 Million by 2034, At a CAGR of 7.89%
Mexico LED Lights Market 2026 : Industry Size to Reach USD 2,904.4 Million by 20 …
IMARC Group has recently released a new research study titled "Mexico LED Lights Market Size, Share, Trends and Forecast by Product Type, Application, Import and Domestic Manufacturing, and Region, 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Market Overview The Mexico LED lights market was valued at USD 1,466.9 million in 2025 and is projected to
Mexico High-Brightness LED Market Size, Share, Latest Insights and Forecast 2025-2033
Mexico High-Brightness LED Market Size, Share, Latest Insights and Forecast 2025 …
IMARC Group has recently released a new research study titled "Mexico High-Brightness LED Market Size, Share, Trends and Forecast by Application, Distribution Channel, Indoor and Outdoor Application, End-Use Sector, and Region, 2025-2033" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios. Market Overview The Mexico high-brightness LED market size reached USD 349.2 Million in 2024 and is

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &